TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

INVESTORS

INVESTORS

TECHNOLOGY

RESOURCES

RESOURCES

RESOURCES

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

RESOURCES

1/4

Measuring Therapy Effectiveness Through Sensing and Data Control  

 

Find out how we are transforming the medical industry through continuous sensing, computing and transmission to provide the configurable data that physicians need.

 

We've started with intraocular pressure (IOP) sensing to help assess glaucoma therapy effectiveness.

 

 

  

  Press Releases

 

   Sept. 1, 2020

  Injectsense Receives FDA Breakthrough Device Program Designation

  for Continuous IOP Monitoring for Glaucoma

  Media Coverage

  

  Medtech Strategist     July 2020

  Injectsense takes RPM to Ophthalmology & Beyond (paywall-protected)

  The Ophthalmologist     March 12, 2020

  Organ to Cloud Technology is Here

  Glaucoma Physician     Dec. 1, 2019

  Sensor for Continuous IOP Monitoring

 

  New Atlas     Oct. 11, 2019

  Injectable Sensor Designed to Keep an Eye on Glaucoma

  Eyewire News     Oct. 9, 2019

  Injectsense Demonstrates Animal-to-Cloud IOP Sensing Pathway 

  Medical Device News     Oct. 9, 2019

  Injectsense Demonstrates IOP Sensing Pathway for Glaucoma

Careers

Emeryville  |  Twin Cities

Technology

 

Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.

Investors

Injectsense received Series B funding in April of 2019, and is currently engaged in fundraising for Series C. 

Events

OIS Glaucoma Innovation Showcase 2020                           

October 15, 2020

Virtual

ASCRS-ASOA                        

Aug 13-17, 2021

San Francisco 

 

 

The Injectsense Difference

 

Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise. 

CAUTION - Investigational Device. Limited by Federal law to investigational use.

.

 

 

Corporate Headquarters

 

Injectsense, Inc.
2000 Powell St

Suite 1425 
Emeryville, CA 94608

 

(510) 292-4120
 

 

 

Twin Cities

 

Injectsense, Inc.

7825 Washington Ave. South

Suite 650

Minneapolis, MN 55439

 

 

 

 

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Facebook Social Icon